| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 5 557-562, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
C D'Ambrosio, SR Keller, A Morrione, GE Lienhard, R Baserga and E Surmacz
Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
The role of the insulin receptor substrate 1 (IRS-1) in cellular transformation was studied in R- cells, which are 3T3-like fibroblasts derived from mouse embryos with a targeted disruption of the insulin-like growth factor I receptor gene. These cells cannot be transformed by oncogenes that readily transform cells originating from wild-type littermate embryos (or other 3T3-like cells). In the present study, we demonstrate that in R- cells, the overexpression of the functional IRS-1 protein was sufficient to induce a mitogenic response to insulin but did not promote transformation, as measured by colony formation in soft agar. The coexpression of IRS-1 and the SV40 T antigen, however, induced transformation. Conversely, expression of an antisense IRS-1 RNA reversed the transformed phenotype in wild-type cells carrying the T antigen. Since the type 1 insulin-like growth factor receptor, by itself, is fully transforming, we propose the hypothesis that the transforming competence of this receptor is based on at least two signaling pathways, one of which is IRS-1-dependent, whereas the other(s) can be substituted with the SV40 T antigen.
This article has been cited by other articles:
![]() |
S. R. Parathath, L. A. Mainwaring, A. Fernandez-L, D. O. Campbell, and A. M. Kenney Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors Development, October 1, 2008; 135(19): 3291 - 3300. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shi, L. Sepp-Lorenzino, M. Prisco, P. Linsley, T. deAngelis, and R. Baserga Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells J. Biol. Chem., November 9, 2007; 282(45): 32582 - 32590. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dalmizrak, A. Wu, J. Chen, H. Sun, F. E. Utama, D. Zambelli, T. H. Tran, H. Rui, and R. Baserga Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells Cancer Res., March 1, 2007; 67(5): 2124 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Dearth, X. Cui, H.-J. Kim, I. Kuiatse, N. A. Lawrence, X. Zhang, J. Divisova, O. L. Britton, S. Mohsin, D. C. Allred, et al. Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2 Mol. Cell. Biol., December 15, 2006; 26(24): 9302 - 9314. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Spence, A. L. Shaffer, L. M. Staudt, S. Amde, S. Manney, C. Terry, K. Weisz, and P. Nissley Transformation of Late Passage Insulin-Like Growth Factor-I Receptor Null Mouse Embryo Fibroblasts by SV40 T Antigen. Cancer Res., April 15, 2006; 66(8): 4233 - 4239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wu, X. Tu, M. Prisco, and R. Baserga Regulation of Upstream Binding Factor 1 Activity by Insulin-like Growth Factor I Receptor Signaling J. Biol. Chem., January 28, 2005; 280(4): 2863 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Evert, J. Sun, S. Pichler, N. Slavova, R. Schneider-Stock, and F. Dombrowski Insulin Receptor, Insulin Receptor Substrate-1, Raf-1, and Mek-1 during Hormonal Hepatocarcinogenesis by Intrahepatic Pancreatic Islet Transplantation in Diabetic Rats Cancer Res., November 1, 2004; 64(21): 8093 - 8100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kelly-Welch, H. Y. Wang, L.-M. Wang, J. H. Pierce, G. Jay, F. Finkelman, and A. D. Keegan Transgenic Expression of Insulin Receptor Substrate 2 in Murine B Cells Alters the Cell Density-Dependence of IgE Production In Vitro and Enhances IgE Production In Vivo J. Immunol., March 1, 2004; 172(5): 2803 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chang, Y. Li, M. F. White, J. A. Fletcher, and S. Xiao Constitutive Activation of Insulin Receptor Substrate 1 Is a Frequent Event in Human Tumors: Therapeutic Implications Cancer Res., November 1, 2002; 62(21): 6035 - 6038. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, X. Qi, M. Williams, Y. Shi, and A. D. Keegan Overexpression of Insulin Receptor Substrate-1, But Not Insulin Receptor Substrate-2, Protects a T Cell Hybridoma from Activation-Induced Cell Death J. Immunol., June 15, 2002; 168(12): 6215 - 6223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Luis Del Valle, S. Enam, A. Lassak, J. Y. Wang, S. Croul, K. Khalili, and K. Reiss Insulin-like Growth Factor I Receptor Activity in Human Medulloblastomas Clin. Cancer Res., June 1, 2002; 8(6): 1822 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lassak, L. Del Valle, F. Peruzzi, J. Y. Wang, S. Enam, S. Croul, K. Khalili, and K. Reiss Insulin Receptor Substrate 1 Translocation to the Nucleus by the Human JC Virus T-antigen J. Biol. Chem., May 3, 2002; 277(19): 17231 - 17238. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Valentinis and R Baserga IGF-I receptor signalling in transformation and differentiation Mol. Pathol., June 1, 2001; 54(3): 133 - 137. [Abstract] [Full Text] |
||||
![]() |
M. Gatzka, M. Prisco, and R. Baserga Stabilization of the Ras Oncoprotein by the Insulin-like Growth Factor 1 Receptor during Anchorage-independent Growth Cancer Res., August 1, 2000; 60(15): 4222 - 4230. [Abstract] [Full Text] |
||||
![]() |
A. V. Lee, J. L. Gooch, S. Oesterreich, R. L. Guler, and D. Yee Insulin-Like Growth Factor I-Induced Degradation of Insulin Receptor Substrate 1 Is Mediated by the 26S Proteasome and Blocked by Phosphatidylinositol 3'-Kinase Inhibition Mol. Cell. Biol., March 1, 2000; 20(5): 1489 - 1496. [Abstract] [Full Text] |
||||
![]() |
A. V. Lee, J. G. Jackson, J. L. Gooch, S. G. Hilsenbeck, E. Coronado-Heinsohn, C. K. Osborne, and D. Yee Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo Mol. Endocrinol., May 1, 1999; 13(5): 787 - 796. [Abstract] [Full Text] |
||||
![]() |
A. Morrione, B. Valentinis, S.-q. Xu, G. Yumet, A. Louvi, A. Efstratiadis, and R. Baserga Insulin-like growth factor II stimulates cell proliferation through the insulin receptor PNAS, April 15, 1997; 94(8): 3777 - 3782. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Valentinis, M. Navarro, T. Zanocco-Marani, P. Edmonds, J. McCormick, A. Morrione, A. Sacchi, G. Romano, K. Reiss, and R. Baserga Insulin Receptor Substrate-1, p70S6K, and Cell Size in Transformation and Differentiation of Hemopoietic Cells J. Biol. Chem., August 11, 2000; 275(33): 25451 - 25459. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |